The forecasts for the next five years are even better, with savings estimated at half a billion euros.
The generic drugs that entered the market in Romania, in the last seven years, brought important savings to the budget of the National Health Insurance Company. The announcement was made by the manufacturers of these drugs at a specialized conference, and the forecasts for the next five years are even better, namely savings of half a billion euros.
Present at the event, Prime Minister Marcel Ciolacu declared that it is time for Romania to start producing innovative medicines.
“The costs for innovative medicines represent 80% of the House’s expenses and 20% the genetic ones. Making generic drugs cheaper is not a successful thing. Decisions must be made with real information and very well argued, so that we balance between generic and innovative. Moreover, on the territory of Romania, regardless of whether we are talking about Romanian shareholders or another type of shareholders, but we are talking about companies that work on the territory of Romania, so they are Romanian companies, that we are talking about Antibiotice or Terapia from Cluj, it is normal that they are a added value for Romania. Romania must move to the second stage, in which innovative medicines must also be produced on Romanian territory“, declared Prime Minister Marcel Ciolacu. /editor Florin Lepadatu/
